7 resultats trouvés
Auteur Titre [ Type
] Année Filtres: Auteur est Tsuji, Atsushi B [Clear All Filters]
67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice.,
, Nucl. Med. Commun., Volume 38, Number 4, p.347–355, (2017)
$\alpha$V$\beta$3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.,
, Mol. Cancer Ther., Volume 15, Number 9, p.2076–2085, (2016)
Micro-positron emission tomography/contrast-enhanced computed tomography imaging of orthotopic pancreatic tumor-bearing mice using the $\alpha$v$\beta$3 integrin tracer 64Cu-labeled cyclam-RAFT-c(-RGDfK-)4.,
, Mol. Imaging, Volume 12, Number 6, p.376–387, (2013)
Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide,
, Cells, 11/2022, Volume 11, (2022)
PET imaging and biodistribution analysis of the effects of succinylated gelatin combined with L-lysine on renal uptake and retention of 64Cu-cyclam-RAFT-c(-RGDfK-)4in vivo.,
, Eur. J. Pharm. Biopharm., Volume 86, Number 3, p.478–486, (2014)
Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer,
, Clinical Cancer Research, 09/2020, Volume 26, Issue 23, p.6230-6241, (2020)
Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.,
, EJNMMI Res., Volume 8, Number 1, p.1–10, (2018)